AnaptysBio, Inc. ANAB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $248.47M+152% | $238.2M+93.5% | $109.83M-42.7% | $44.3M-38.3% | $98.64M+83.7% | ||
| $37.99M-84.3% | $73.44M-72.0% | $139.12M-41.7% | $221.41M-20.6% | $241.3M-19.8% | ||
| $25.75M+44.0% | $33.85M-17.0% | $75.69M+521% | $21.42M+138% | $17.88M+152% | ||
| $3.91M-26.2% | $4.76M-17.0% | $6.01M-5.7% | $4.78M-36.6% | $5.29M-50.4% | ||
| $316.11M-12.9% | $350.25M-18.9% | $330.65M-26.3% | $291.91M-20.5% | $363.11M-2.5% | ||
| $1.28M-26.5% | $1.37M-25.9% | $1.5M-13.2% | $1.63M-11.2% | $1.74M-10.9% | ||
| $12.04M-13.5% | $12.52M-13.0% | $12.99M-12.4% | $13.46M-11.9% | $13.92M-11.5% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $329.68M-21.9% | $364.4M-24.7% | $353.1M-28.4% | $335.25M-21.6% | $422.05M+4.0% | ||
| $7.52M+22.8% | $3.87M-3.3% | $2.89M-19.5% | $3.33M-31.9% | $6.12M+33.6% | ||
| $32.07M-10.8% | $32.67M-17.3% | $33.17M-13.6% | $30.2M-10.3% | $35.95M+38.8% | ||
| $2.12M+8.1% | $2.08M+8.1% | $2.04M+8.1% | $2M+8.2% | $1.96M+8.2% | ||
| $41.7M-5.3% | $38.63M-15.0% | $38.1M-13.2% | $35.53M-12.1% | $44.04M+36.3% | ||
| $11.49M-15.6% | $12.03M-14.7% | $12.57M-14.0% | $13.1M-13.3% | $13.61M-12.6% | ||
| $13.61K-99.9% | $14.11K-99.9% | $14.61M-11.4% | $15.1M-10.9% | $15.58M-10.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $29K-3.3% | $28K-6.7% | $28K-6.7% | $28K+3.7% | $30K+11.1% | ||
| $838.31M+0.7% | $809.77M-2.4% | $792.68M-3.5% | $792.53M+10.8% | $832.49M+17.8% | ||
| -$825.44M-3.4% | -$772.56M-1.7% | -$822.17M-11.5% | -$837.29M-18.8% | -$798.66M-21.4% | ||
| -$146K-191% | -$24K-108% | $47K-93.8% | -$6K+98.6% | $161K+126% | ||
| $12.75M-62.5% | $37.21M-47.5% | -$29.42M-135% | -$44.73M-553% | $34.02M-28.8% | ||
| $329.68M-21.9% | $364.4M-24.7% | $353.1M-28.4% | $335.25M-21.6% | $422.05M+4.0% | ||
| $37.99M-84.3% | $73.44M-72.0% | $139.12M-41.7% | $221.41M-20.6% | $241.3M-19.8% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $12.04M-13.5% | $12.52M-13.0% | $12.99M-12.4% | $13.46M-11.9% | $13.92M-11.5% | ||
| $12.04M-13.5% | $12.52M-13.0% | $12.99M-12.4% | $13.46M-11.9% | $13.92M-11.5% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $12.04M-13.5% | $12.52M-13.0% | $12.99M-12.4% | $13.46M-11.9% | $13.92M-11.5% | ||
| $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | $256K0.0% | ||
| $32.07M-10.8% | $32.67M-17.3% | $33.17M-13.6% | $30.2M-10.3% | $35.95M+38.8% | ||
| $32.07M-10.8% | $32.67M-17.3% | $33.17M-13.6% | $30.2M-10.3% | $35.95M+38.8% | ||
| $13.61K-99.9% | $14.11K-99.9% | $14.61M-11.4% | $15.1M-10.9% | $15.58M-10.4% | ||
| $29K-3.3% | $28K-6.7% | $28K-6.7% | $28K+3.7% | $30K+11.1% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $263.74M-20.2% | $276.53M-21.8% | $331.84M-5.3% | $331.36M-8.5% | $330.38M+6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AnaptysBio, Inc.'s total assets?
- AnaptysBio, Inc. (ANAB) holds $329.7M in total assets, down 21.9% year over year.
- How much debt does AnaptysBio, Inc. have?
- AnaptysBio, Inc. carries $13.6K in total debt against $12.7M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does AnaptysBio, Inc. have?
- AnaptysBio, Inc. holds $248.5M in cash and equivalents.
- Can AnaptysBio, Inc. cover its short-term obligations?
- Its current ratio is 7.58 — current assets exceed current liabilities.
- Where does AnaptysBio, Inc.'s balance sheet data come from?
- Every line is extracted from AnaptysBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
